Free Trial

Bellevue Healthcare (LON:BBH) Stock Price Down 0.2% - What's Next?

Bellevue Healthcare logo with Financial Services background

Bellevue Healthcare (LON:BBH - Get Free Report)'s share price dropped 0.2% during mid-day trading on Monday . The company traded as low as GBX 117.80 ($1.60) and last traded at GBX 119 ($1.61). Approximately 3,210,911 shares traded hands during trading, an increase of 38% from the average daily volume of 2,329,367 shares. The stock had previously closed at GBX 119.20 ($1.62).

Bellevue Healthcare Price Performance

The firm has a market cap of £296.73 million and a P/E ratio of -18.31. The company's 50-day simple moving average is GBX 118.92 and its 200 day simple moving average is GBX 131.84.

Bellevue Healthcare (LON:BBH - Get Free Report) last announced its quarterly earnings results on Tuesday, March 18th. The company reported GBX 0.03 ($0.00) EPS for the quarter. Bellevue Healthcare had a net margin of 169.10% and a negative return on equity of 4.48%.

Bellevue Healthcare Dividend Announcement

The business also recently disclosed a dividend, which was paid on Friday, May 30th. Stockholders of record on Thursday, May 1st were paid a GBX 2.52 ($0.03) dividend. This represents a dividend yield of 2.01%. The ex-dividend date of this dividend was Thursday, May 1st. Bellevue Healthcare's payout ratio is -91.26%.

Bellevue Healthcare Company Profile

(Get Free Report)

Bellevue Healthcare Trust plc is a high conviction, long-only investment trust invested in listed or quoted global healthcare equities. It is unconstrained and able to invest regardless of market cap, sub sector or region, and the portfolio is concentrated with a maximum of 35 holdings. The target total dividend in the first financial period is 3.5 pence per ordinary share (to be paid mostly out of capital) and in subsequent financial years will be set at 3.5 per cent.

Read More

Should You Invest $1,000 in Bellevue Healthcare Right Now?

Before you consider Bellevue Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bellevue Healthcare wasn't on the list.

While Bellevue Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines